Health groups challenging Trump’s claims about Tylenol and autism are closely aligned with pharmaceutical companies.
Health Groups Challenge Autism Claims by Trump Administration Health organizations have voiced strong disapproval of the Trump administration’s recent stance on autism, bringing attention to the potential implications from a healthcare viewpoint. However, it’s interesting to note that many of these groups have close connections with pharmaceutical companies. President Donald Trump and Health Secretary Robert […]
Harvard dean referenced in Trump’s Tylenol alert was a paid expert witness in 2023 lawsuit against the pharmaceutical company.
Research from Harvard that looks into the impact of Tylenol on pregnant women has surfaced amidst a warning from President Trump advising expectant mothers to steer clear of the drug. Dr. Andrea Bacarelli, the dean at Harvard’s T.H. Chan School of Public Health, recently co-authored a research review discussing acetaminophen, a common pain reliever, and […]
Pharmaceutical Company Introduces Medication at Identical Price in U.S. and Europe
Bristol Myers Squibb (BMS) announced on Monday that its new flagship drug will be available in international markets at the same price as in the US. The schizophrenia medication Cobenfy (Xanomeline and Trospium) is scheduled for a 2026 launch in the UK, priced equally to its US counterpart. Adam Lenkowsky, BMS’s Chief Commercialization Officer, stated: […]
PCOS overlooked as pharmaceutical companies gain from women’s infertility
Fertility Rates: A Growing Concern The drop in fertility rates has caught everyone’s attention for several understandable reasons. In the U.S., the fertility rate has fallen to 1.6 births per woman—well below the replacement level of 2.1. Earlier this year, the Trump administration suggested a plan to counteract this trend—a $5,000 single “baby bonus,” along […]
Pharmaceutical companies want to eliminate PBMs since they save patients a lot of money.
Senate Bill Targets Prescription Drug Pricing Recently, a bipartisan group of senators proposed new drug pricing laws aimed at addressing the role of pharmacy benefit managers (PBMs). Over the years, pharmaceutical companies have portrayed PBMs as villains in the prescription supply chain, arguing that these intermediary agents inflate prices and stifle innovation. This narrative is […]
See RFK Jr. target the pharmaceutical industry with a humorous drug advertisement.
Parody Video Targets Pharmaceutical Advertising In a recent move, Robert F. Kennedy Jr. and the Department of Health and Human Services introduced a parody video aimed at critiquing consumer-targeted pharmaceutical ads. This follows the unveiling of a new strategy focused on tackling misleading advertisements in the drug industry. The parody kicks off with a line […]
Health care expenses are rising significantly. Hold insurers, pharmaceutical companies, and your employer accountable.
In the United States, healthcare is quite costly, even by developed nations’ standards, and it seems prices are climbing even higher. About 154 million people receive health insurance through their employers, and many are noticing their deductions on paychecks spiking next year. Alongside this, out-of-pocket costs may also rise as employers look to offset the […]
Trump administration takes aim at major pharmaceutical companies for misleading drug promotions
Trump Administration Targets Misleading Drug Advertisements The Trump administration is working on new regulations to address loopholes that allow misleading drug advertisements to downplay safety risks in both broadcast and digital formats. On Tuesday, the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) sent out thousands of warning letters […]
Trump writes to pharmaceutical companies asking for reduced prescription costs
President Donald Trump has recently reached out to pharmaceutical companies in a letter, urging them to reduce drug prices, as outlined in an executive order signed in May. However, experts note that Trump’s capacity to compel these companies to lower their prices is limited, as his approach effectively constitutes price control. This strategy of applying […]
Trump calls on pharmaceutical companies to reduce drug prices within the next 60 days.
On Thursday, President Trump reached out to 17 of the largest pharmaceutical companies in the world, urging that more be done to lower prescription drug prices, aligning them with the lowest prices found in some foreign nations. This letter highlights a push to implement a “most preferred country” pricing model, which would base U.S. prescription […]